NASDAQ: FTH

Faeth Therapeutics, Inc.

$25.52
-0.42 (-1.62%)as of 2026-07-17
1-year price · 252 sessions
Key stats
52-week range$25.52
$6.80$36.16
Today
Open
24.52
Day high
26.22
Day low
23.82
Prev close
25.94
Volume
94K
Valuation
Mkt cap
$34M
P/E (TTM)
EPS (TTM)
P/B
P/S
Dividend
Yield
Per share
Insider & institutional activity · SEC Form 4 / 13F
  • Insiders net buying $1.2M over the last 3 months (22 open-market buys, 0 sales)
  • Cluster buying — multiple insiders bought within days
See all FTH insider trades →

Faeth Therapeutics, Inc. (FTH) is a Healthcare company listed on NASDAQ. The stock is up 230% over the past year. Over the trailing 3 months, insiders filed 22 open-market buys and 0 sales (SEC Form 4).

Faeth Therapeutics, Inc. (FTH) financials & analyst ratings

Fundamentals (TTM)

Margins
Gross margin2740.8%
Operating margin3826.9%
Net margin3802.5%
FCF margin497.1%
Growth & returns
Revenue growth
Revenue growth (fwd)
EPS growth
Return on equity-96.5%
Return on assets-89.8%

Analyst consensus · 3 analysts

BuyBuy 3Hold 0Sell 0Avg target $57 (+124.6%)Range $55–$60

Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.

Track FTH with Drillr

SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.

Try Drillr for free